Sequence of Treatments May Induce Clinical Response in Metastatic Renal Cell Carcinoma Patients

HOLLYWOOD, Fla., March 13, 2008 — Several recently approved agents offer promising treatment possibilities for patients with metastatic renal cell carcinoma (RCC) and the order in which these agents are administered may positively impact clinical response, according to a presentation given during the National Comprehensive Cancer Network (NCCN) 13th Annual Conference: Clinical Practice GuidelinesandQuality Cancer Care. Until recently, there were very few agents to treat RCC and those available ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news